戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (rifght1)

通し番号をクリックするとPubMedの該当ページを表示します
1           Among 842 infants hospitalized for bronchiolitis, there was 88% follow-up at 3 years, and 31% had recurrent whe
2 ring pre-Affordable Care Act with post-Affordable Care Act, there was a 4.75% increase in medicaid coverage and a 1.91% d
3                   In contrast, for each 10% increase in WHR there was a 75% increase (95% confidence interval [CI] = 44-1
4                            When 25% participated (n = 101), there was a 9.1% relative reduction in incident carriers (20.
5                                                             There was a monotonic relationship between hospital occupancy
6                                                             There was a quadratic fit between time per bite and bite mass
7     On the other hand, within the cART suppressed macaques, there was a reduction in cell-associated DNA load, intact pro
8                                                             There was a significantly higher WCC(P=0.014) and CRP(P=0.004
9 ing outcomes of MMCR vs ELR in patients with severe ptosis, there was a statistically significant higher rate of success
10                                                             There was a statistically significant increase in the relativ
11                                                             There was a strong positive correlation between 11C-PK-11195
12  was significantly related to height, BMI and age, and that there was an acceleration in muscle volume decrease in men wi
13                                                             There was an association between IgG1 titer and SNP rs3901533
14                       Among the many host genes identified, there was an enrichment in genes localizing to the mitochondr
15  stabilization of T2/FLAIR abnormalities, and after 2 years there was complete resolution of abnormal multifocal reduced
16                                                             There was enrichment of proteins associated with inflammation
17                                            Within patients, there was greater relative weakness (lower MRC score) in thum
18                                With increasing axial length there was greater vitreous echodensity (R: 0.573; P < .01) an
19 ts' beliefs and found no difference in the speed prior, but there was heightened variability in the ASD group.
20 dy provided some evidence for a 'parity-frailty trade-off', there was little support for our hypothesis that the physiolo
21                                                             There was no apparent interaction between Px and Iso treatmen
22                                                             There was no association between liver stiffness and any pati
23                                                             There was no association with ART initiation in the hospital
24                                                             There was no change in IGF-1 level from before to after surge
25                                                    However, there was no consensus on the relevance of REA, including how
26                                                             There was no difference between the two interventions on the
27                                                             There was no difference in adverse events between randomised
28                                                             There was no discordance when all the echocardiographic param
29                                                  Similarly, there was no dose-dependent relationship between PPS exposure
30                                                             There was no evidence for associations of physical activity w
31                                                             There was no evidence of interaction between MRD status and c
32                                                             There was no evidence that concussion or vision symptom traje
33  earlier and had no medical history of note; in particular, there was no history of cancer or predisposing factors for ch
34                                                             There was no masking in this open-label trial.
35                         In multivariable adjusted analyses, there was no significant association between baseline eGFR <6
36                                                             There was no significant association between donor MDRO and e
37                                                             There was no significant association between the duration of
38 re significantly lower in IUGR than control foetuses, while there was no significant difference among IUGR groups.
39 iated with improvement of these energetic changes such that there was no significant difference in comparison with contro
40 ophrenia with large effect sizes (Cohen's d = 0.8-0.9), but there was no significant difference in the hippocampus.
41                                                  Similarly, there was no significant difference within different types of
42                                                             There was no statistically significant difference in readmiss
43 all-cause mortality (HR, 0.83 [95% CI, 0.75-0.92]), whereas there was no statistically significant mortality reduction wi
44                                                             There was no toxic mortality.
45                                                             There was one family with macular dystrophy, nine with cone-r
46                                                             There was one maternal death attributed to underlying disease
47                                                             There was only slight agreement between whole-body MRI and CT
48 reased over time (P value for trend test <0.0001); however, there was significant variation in rates across hospital site
49 across population subsets relative to sample weighting, and there was some evidence of small gains in precision when usin
50                                 On brain MRI, within 1 year there was stabilization of T2/FLAIR abnormalities, and after